Presse | ANRS

LES DERNIERS COMMUNIQUéS DE PRESSE

Autre

Communiqué

Human epithelial cell infected with Chlamydia trachomatis © ZEISS Microscopy / Courtesy of Dr. Volker Brinkmann, Max Planck Institute for Infection Biology, Berlin/Germany

22/02/2023

New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Bacterial STIs and proven efficacy of the MVA-BN Vaccine Against Mpox

VIH

Communiqué

Crédit : Mufid Majnun / Unsplash

22/02/2023

A HIV Vaccine Candidate Demonstrates Its Safety and Capacity to Induce an Immune Response

VIH
Hépatites
Covid-19
Institution

Communiqué

Signature PRISME Cote d'Ivoire / DR

24/01/2023

Reinforcing the Franco-Ivorian Partnership Through the Creation of an International Research Platform in Global Health

Autre

Communiqué

Efficacité d’un vaccin contre le méningocoque B et d’un antibiotique préventif pour réduire le risque d’infections sexuellement transmissibles

21/10/2022

Efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Sexually Transmitted Infections

Institution

Communiqué

20/09/2022

Building a European partnership for Pandemic Preparedness: The project BE READY

Actualités

monkeypox virus

05
Aug
2022

Results of the monkeypox "Flash" call for projects

EDCTP-3

11
May
2022

ANRS DATURA and DREAMM, two promising projects to combat…

Dernières ressources

CONTACTS PRESSE

ANRS (France Recherche Nord
& Sud Sida-HIV hépatites)

information@anrs.fr

101, rue de Tolbiac, 75013 Paris

Si vous souhaitez recevoir nos communiqués